Company / Free Cash Flow per Share
Supernus Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.83
FY2025
5-year range
$0.83 / $3.13
FY2021-FY2025
Trend
-73.6%
vs FY2024
Sector context
#52 of 192
Health Care
What the data says
At $0.83, Supernus Pharmaceuticals, Inc.'s free cash flow per share ranks #52 of 192 in the Health Care sector. Free Cash Flow per Share has fluctuated over the past 9 years, ranging from $-0.51 in FY2016 to $3.13 in FY2024.
Based on SEC 10-K filings.
0.83 in FY2025 with a 5-year CAGR of -20.3%.
Declined from $1.99 to $0.83 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -27.7%
- 5-Year CAGR
- -20.3%
- 10-Year CAGR
- -
Sector benchmark
#52 of 192 in Health CareTop 27% of 192This company $0.83 Sector average -$19.84
▼
+104.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 73.6% year-over-year.
- Ranks #52 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.83 | -73.6% |
| FY2024 | $3.13 | +57.1% |
| FY2023 | $1.99 | -8.9% |
| FY2022 | $2.19 | - |
| FY2021 | - | - |
| FY2020 | $2.57 | -4.3% |
| FY2019 | $2.68 | +111.2% |
| FY2018 | $1.27 | +95.9% |
| FY2017 | $0.65 | +226.7% |
| FY2016 | -$0.51 | -167.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026